TRICLOSAN
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
监管决定及完整条件
- 状态
- Restricted
- 法律地位
- Binding rule
- 监管摘要
- The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
- 条件与限制
TRICLOSAN in cosmetic preparations for human use containing more than 0.3% of triclosan.
物质身份
- 官方来源名称
- TRICLOSAN
- CAS
- 3380-34-5
- EC
- 222-182-2
- 身份映射
- exact_name
- 关联成分
- TRICLOSAN
关联的 CosIng 身份数据
名称和别名
CosIng 描述: 5-Chloro-2-(2,4-dichlorophenoxy)phenol
欧盟清单限制备注: V/25
已记录的化妆品功能: ANTIMICROBIAL, DEODORANT, PRESERVATIVE
功能页面:ANTIMICROBIAL, DEODORANT, PRESERVATIVE
查看完整的成分档案该身份的跨市场概览
本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。
European Union
1 条关联记录 · 1 条含特定条件
打开支持记录Great Britain
1 条关联记录 · 1 条含特定条件
打开支持记录Canada
1 条关联记录 · 1 条含特定条件
打开支持记录New Zealand
1 条关联记录 · 1 条含特定条件
打开支持记录ASEAN
2 条关联记录 · 2 条含特定条件
打开支持记录South Korea
1 条关联记录 · 1 条含特定条件
打开支持记录Australia
当前记录1 条关联记录 · 1 条含特定条件
打开支持记录
CAS 3380-34-5 的已核实化学信息
Triclosan
Triclosan is an aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. It has a role as an EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor, a fungicide, an antibacterial agent, a xenobiotic, an antimalarial, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a persistent organic pollutant and a drug allergen. It is a dichlorobenzene, a member of phenols, an aromatic ether and a member of monochlorobenzenes. — ChEBI
- IUPAC 名称
- 5-chloro-2-(2,4-dichlorophenoxy)phenol
- 分子式
- C12H7Cl3O2
- 分子量
- 289.5 g/mol
- 精确质量
- 287.951163 Da
- 单同位素质量
- 287.951163 Da
- XLogP3
- 5.0
- 拓扑极性表面积
- 29.5 Ų
- 分子复杂度
- 252.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 2
- 可旋转键
- 2
- 重原子
- 17
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 4
- 三维环
- 2
- 三维疏水基团
- 0
- 三维受体特征
- 1
- 三维供体特征
- 1
- 三维阴离子中心
- 0
- 三维阳离子中心
- 0
- 三维构象异构体
- 10
- 有效三维可旋转键
- 2.0
机器可读的结构标识符
- SMILES
C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl- InChI
InChI=1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H- InChIKey
XEFQLINVKFYRCS-UHFFFAOYSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与出处
- 已登记来源
- Australia Poisons Standard (SUSMP)
- 来源参考
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6
- 来源记录 ID
schedule-6:triclosan:67- 来源版本
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
- 来源语言
- English
- 翻译状态
- Original is English
- 生效日期
- 2026-06-01
- 来源更新
- 2026-05-28
- 快照检查时间
- 2026-08-31 15:26 UTC
- 验证方法
- pdftotext -layout; 674 pages; exact cosmetic-relevant per-schedule counts {2: 4, 4: 12, 5: 15, 6: 62, 10: 32}
- SHA-256
38478bdefd4ebaf571ac39001e2ce35026a7edafbaec995e75746ce69a650e11
已登记的数据集备注
- 数据集覆盖范围
- All current Poisons Standard entries whose source wording explicitly covers cosmetics or personal-care uses
- 权威性说明
- Binding Commonwealth scheduling instrument; state and territory implementation and AICIS duties still apply
本记录在市场数据集中的位置
Australia 市场背景
Complete cosmetic-relevant Poisons Standard subset plus official workflow
覆盖版本: Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
All 125 current Schedule 2, 4, 5, 6 and 10 entries whose legal wording explicitly covers cosmetics or personal-care uses, plus AICIS verification links.
核实清单
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
官方市场来源
- Australia AICIS InventoryNot an allowed/banned cosmetics list; use for per-CAS enrichment and source links
- Australia Poisons Standard (SUSMP)Binding Commonwealth scheduling instrument; state and territory implementation and AICIS duties still apply
- Australia AICIS banned or restricted chemicals guidanceWorkflow guidance, not an exhaustive ingredient list
核实工作流程与记录完整性
在将此结果用于合规决定之前
- 确认“TRICLOSAN”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
- 记录来源版本,并在生产、备案或上市之前重新核查监管机构。
本记录中的可用字段
- 官方物质名称可用
- CAS可用
- EC可用
- 单独的条件文本可用
- 生效日期可用
- 快照哈希与方法可用
本页回答的问题
稳定引用
TRICLOSAN. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6. Australia. Source version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/au/records/13173/
请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。
Australia 的解读与局限
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
如何解读法律地位
The cited row forms part of a binding rule or legally incorporated list for this market.
本页证据
- 记录结果:Restricted
- 法律地位:Binding rule
- 来源版本:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
- 生效日期:2026-06-01
它不能证明什么
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
进一步的权威物质研究
这些来源均不能推翻上述市场决定。
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
在来源处研究此身份FDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
在来源处研究此身份ILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
在来源处研究此身份Japan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
在来源处研究此身份NIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
在来源处研究此身份OECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
在来源处研究此身份US EPA CompTox CTX APIs
导入需要 API 密钥DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
在来源处研究此身份